UMIN-CTR Clinical Trial

Basic information
Public title	Study of the effect of a drink containing lactic acid bacteria on bowel movement, intestinal flora and fecal properties in subjects with constipation tendency. : A randomized, double blinded, placebo controlled study
Acronym	Study of the effect of a drink containing lactic acid bacteria on bowel movement,intestinal flora and fecal properties in subjects with constipation tendency.
Scientific Title	Study of the effect of a drink containing lactic acid bacteria on bowel movement, intestinal flora and fecal properties in subjects with constipation tendency. : A randomized, double blinded, placebo controlled study
Scientific Title:Acronym	Study of the effect of a drink containing lactic acid bacteria on bowel movement,intestinal flora and fecal properties in subjects with constipation tendency.
Region	Japan South America

Condition
Condition	Healthy adult
Classification by specialty	Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	This study aimed to verify the effect of drink containing lactic acid bacteria on bowel movement, fecalproperties in subjects with constipation tendency for 2 weeks.
Basic objectives2	Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	Defecation frequency Evaluate two weeks after starting ingestion.
Key secondary outcomes	Defecation days, Fecal amount, Fecal properties. Intestinal flora(Real-Time PCR). Fecal moisture. Fecal pH. The fecal concentrations of ammonia.

Base
Study type	Interventional

Study design
Basic design	Parallel
Randomization	Randomized
Randomization unit	Individual
Blinding	Double blind -all involved are blinded
Control	Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	2
Purpose of intervention	Prevention
Type of intervention	Food
Interventions/Control_1	Ingestion of test product for 2 consecutive weeks
Interventions/Control_2	Ingestion of placebo for 2 consecutive weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	64 years-old >=
Gender	Male and Female
Key inclusion criteria	(1)males and females from 20 to 64 years of age (2)Subjects who answered that the usual defecation frequency was 5 or less per week in the questionnaire (3)Subjects with constipation tendency and lower defecation frequency during screening period
Key exclusion criteria	(1)Subjects who cannot restrict the use of medicines or health foods that may influence their bowel movements after informed consent (2)Subjects visiting the hospital for diseases related bowel movements and using drugs, or are regularly using commercially available constipation medicine (3)Subjects currently undergoing treatment or with digestive diseases that affect the study or have a surgical history of digestive system(except appendicectomy) (4)Subjects with diseases (irritable enteritis, ulcerative colitis,etc.) affecting bowel movement or have a history of these diseases (5)Subjects who are under treatment or have a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease) (6)Subjects judged as unsuitable for this study based on the results of clinical examination or cardiopulmonary abnormality (7)Subjects have a deseases requiring regular medication or a history of serious diseases for which medication was required (8)Subjects have possibilities to develop an allergy to the test product (9)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (10)Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (11)Subjects who have participated in other clinical studies (12)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating (13)Subjects judged as unsuitable for the study by the investigator for other reasons
Target sample size	100

Research contact person
Name of lead principal investigator	1st name Middle name Last name Jiro Saito
Organization	Medical Station Clinic
Division name	None
Zip code
Address	3-12-8 Takabann, Meguro-ku, Tokyo, Japan
TEL	03-6452-2712
Email	info@med-station.jp

Public contact
Name of contact person	1st name Middle name Last name Chiharu Goto
Organization	TTC Co., Ltd.
Division name	Clinical Research Planning Department
Zip code
Address	Seibu Shinkin Bank Ebisu Bldg., 1-20-2, Ebisunishi, Shibuya-ku, Tokyo, Japan
TEL	03-5459-5329
Homepage URL
Email	c.goto@ttc-tokyo.co.jp

Sponsor
Institute	TTC Co., Ltd.
Institute
Department

Funding Source
Organization	Nissin York Co.,Ltd.
Organization
Division
Category of Funding Organization	Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2018 Year 12 Month 10 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Completed
Date of protocol fixation	2018 Year 11 Month 22 Day
Date of IRB	2018 Year 11 Month 22 Day
Anticipated trial start date	2018 Year 12 Month 11 Day
Last follow-up date	2019 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date	2018 Year 12 Month 10 Day
Last modified on	2019 Year 11 Month 06 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040114